XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and Complications

Purpose. To evaluate gel microstent (XEN, Aquesys, Inc) for treatment of primary open angle glaucoma (POAG). Methods. In this prospective interventional study, 13 eyes with POAG underwent XEN implantation with subconjunctival mitomycin-C. Of those eyes, 3 were pseudophakic and 10 underwent simultane...

Descripción completa

Detalles Bibliográficos
Autores principales: Galal, Ahmed, Bilgic, Alper, Eltanamly, Rasha, Osman, Amr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350531/
https://www.ncbi.nlm.nih.gov/pubmed/28348884
http://dx.doi.org/10.1155/2017/5457246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350531/
https://www.ncbi.nlm.nih.gov/pubmed/28348884
http://dx.doi.org/10.1155/2017/5457246

Ejemplares similares